02.12.2016 14:45:00

The Next Biggest Industry Could Potentially Be Cannabis

NEW YORK, December 2, 2016 /PRNewswire/ --

The state of California is anticipated to triple the size of the legal cannabis market when the state begins issuing licenses in 2018, which makes up 12 percent of the United States, according to market research firm Cowen Group. Vivien Azer, a cannabis analyst at Cowen, believes the nation's legal market will raise nine fold over the next decade, with consumers spending of $50 billion on recreational and medical marijuana by 2026. Lithium Corp (OTC: LITH), Medical Marijuana Inc. (OTC: MJNA), Cannabis Science Inc. (OTC: CBIS), Terra Tech Corporation (OTC: TRTC), Cannabics Pharmaceuticals Inc. (OTC: CNBX)

Whether you have bad or good thoughts about the election results, it was a good year for thus far for the cannabis industry. California, Massachusetts and Nevada and Maine legalized cannabis. These major states could be the reflection of the country's changing opinions toward cannabis, both for medical and recreational purposes. Now more than 20 percent of Americans can use cannabis or marijuana legally.

Lithium Corp (OTC: LITH) recently announced the relaunch of its search engine platform for cannabis related information resource, iWeedz. The platform connects consumers with vendors and individuals to easily find the right strains and products they're seeking for. For vendors, iWeedz will be cloud-based to manage inventory, post notifications for users, and could also market via mobile device, emails, and SMS. This technology platform will be available at http://www.iWeedz.com, and will be assessable with Apple iOS and android devices.

Greg Rotelli, Chief Executive Officer of U.S. Lithium, commented "We spent several years developing the iWeedz platform. We are exploring ways of streamlining the marijuana industry for both consumers and vendors by providing cutting edge scalable solutions that remain easy to use. In researching various opportunities, it was important for us to look at opportunities that were scalable and trendy. With the Green Rush trend, we felt that we could not ignore the interest by the investment community; we felt iWeedz was the right move as it is scalable and can solve a lot of problems consumers and vendors in marijuana commerce are experiencing. As a Company, we feel there is tremendous opportunity for our investors with this diversified approach especially with various upcoming state legislations looking to legalize marijuana."

Medical Marijuana Inc. (OTC: MJNA) announced that its major investment company AXIM® Biotechnologies, Inc. has filed an IP application with the World Intellectual Property Organization on a proprietary method to extract tetrahydrocannabinol acid from cannabis plants and to attain tetrahydrocannabinol (THC) with higher purity than conventional methods being used in the market today. The recently-filed IP would give protection to the invention of a method of extraction of THC-A from the cannabis flower using a solvent where the yield is approximately 50-70 percent with regards to THC-A content in the starting material.

Cannabis Science Inc. (OTC: CBIS) has initiated plans during the middle of November to conduct its long awaited medication study for Pulmonary Patients suffering from varying failing lung functions stemming from Cancers to Bronchitis and all in between respiratory ailments. "We expect it will begin as soon as the First Lab and Extraction site is completed and we think this will take place in this month of November," stated CEO and Co-founder Raymond C. Dabney. The company's goals along with medications are the delivery systems required and deemed to be the most beneficial to the patient. While medications in pill form and/or inhaled medications serve well for maintenance purposes and long term regimens, often times much of a medication's healing benefit is lost through the delivery method.

Terra Tech Corp. (OTCQX: TRTC) currently works through two sectors which consists of Hydroponic Produce and Cannabis Products. The company's subsidiary companies are IVXX™, Edible Garden®, and Blüm™. IVXX hand picks and grows the top quality cannabis using free of toxic pesticides, harmful molds and chemical residues. Blüm is a retail medical cannabis facility focused on providing the highest quality medical cannabis to patients who are looking for alternative treatments for their chronic medical conditions. Edible Garden utilizes time-tested, classic Dutch hydroponic farming methods to grow herbs and leafy greens in a safe and healthy environment.

Cannabics Pharmaceuticals Inc. (OTC: CNBX) has commenced the study in Israel for cancer patients utilizing Cannabics' SR Capsules. This is one of the world's only clinical study explicitly investigating the effects of cannabis utilizing a medically standardized edible delivery system. The company describes itself as a licensed research and development based in Israel dedicated to the development of palliative and personalized Anti-Cancer treatments harnessing the versatile therapeutic values of cannabinoids to create tailored therapies for cancer patients.

Please SIGN UP NOW at http://www.FinancialBuzz.com To Receive Alerts on Trending Financial News from all these companies. "The Latest Buzz in Financial News"  

Subscribe Now! Watch us report from NYSE https://www.youtube.com/FinancialBuzzMedia

Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz

Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz

Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/

About FinancialBuzz.com  

FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR branding, marketing and advertising for third parties for disseminating news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the "Site") is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and pr marketing firm enters into service agreements with the companies which are the subject to the articles posted on the Site for advertising such companies. Financialbuzz.com expects to be compensated four thousand dollars for financial news dissemination and pr services by a non-affiliated third party for u.s. lithium corp. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting high quality and sophisticated content on this site along with other financial news pr media services. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. FinancialBuzz.com does not undertake to update any of the information on the Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security. FinancialBuzz.com, members and affiliates are not responsible for any gains or losses that result from the opinions expressed on the Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. FinancialBuzz.com. By accessing this website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by FinancialBuzz.com constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by FinancialBuzz.com. Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use. Please visit: http://www.financialbuzz.com

For further information: 
Media Contact: info@financialbuzz.com, +1-877-601-1879 

SOURCE FinancialBuzz.com

Nachrichten zu Cannabics Pharmaceuticalsmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Cannabics Pharmaceuticalsmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Medical Marijuana Inc. 0,00 14,29% Medical Marijuana Inc.